In English | En español

National Cancer Institute

at the National Institutes of Health

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI

Clinical Trials Search Results

Page Options

Email This Document

Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat

Popular Resources

Help Using the NCI Clinical Trials Search Form
Learn About Clinical Trials
About NCI's List of Cancer Clinical Trials
NCI Dictionary of Cancer Terms
NCI Drug Dictionary

View Content for:

Patients
Health Professionals

Display:

Title
Description with: Locations Eligibility
Full Trial Description
Custom

Results 1-2 of 2 for your search:

Drug:  calaspargase pegol
Find trials that include:  Any drugs shown
Trial Status:  Closed

Hide Search Criteria

Show Search Criteria

Help with Results

Select All on Page Sort by: Show Results per Page

Biomarkers to Classify Young Patients With Acute Lymphoblastic Leukemia (ALL) and Remission Induction Therapy in Young Patients With B-Precursor ALL

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Health services research, Treatment
Status: Completed
Age: 21 or under at diagnosis
Sponsor: NCI, Other
Protocol IDs: CDR0000078618, COG-9900, POG-9900, NCT01225874

Pilot Randomized Study of SC-PEG E. coli L-Asparaginase (EZN-2285) Versus Pegaspargase With Combination Chemotherapy in Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Temporarily closed
Age: 1 to 30
Sponsor: NCI
Protocol IDs: COG-AALL07P4, AALL07P4, NCT00671034

Select All on Page

Help with Results

We Can Answer Your Questions
1-800-4-CANCER
LiveHelp Online Chat

NCI Home
Contact Us
Policies
Accessibility
Viewing Files
FOIA
Site Help
Site Map

Other Versions of this Site: Mobile | Español

Follow Us:

Twitter
YouTube
Facebook
RSS

NIH…Turning Discovery Into Health^®